SCHEMBL7705332

SCHEMBL7705332

COc1cc(NC(=O)O)c(NC(=O)CC(=O)c2cccc(-n3ccnc3)c2)cc1-c1ccc(F)cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.41
ADH5 P11766 3/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
KCNH2 Q12809 1/20 0.37
CYP3A4 P08684 3/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ABCB1 P08183 2/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
MAPK14 Q16539 1/20 0.36
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7141809 0.91 ABL1 (0.40) ABL1ADH5KMT2AMEN1PDE4A
SCHEMBL7147242 0.81 ABL1 (0.41) ABL1ADH5KMT2AMEN1PDE4A
SCHEMBL7143167 0.79 ABL1 (0.41) ABL1KMT2AMEN1PDE4APDE4B
SCHEMBL5868869 0.79 ADH5 (0.41) ABL1ADH5PDE4APDE4BPDE4C
SCHEMBL7705397 0.79 KMT2A (0.40) KMT2AMEN1MAPT
SCHEMBL7146597 0.78 ADH5 (0.41) ABL1ADH5PDE4APDE4BPDE4C
SCHEMBL7139934 0.75 ABL1 (0.41) ABL1ADH5PDE4APDE4BPDE4C
SCHEMBL7705335 0.75 ALDH1A1 (0.44) KMT2AMEN1CYP3A4CYP2D6ALDH1A1
SCHEMBL7145881 0.74 ABL1 (0.39) ABL1ADH5PDE4APDE4BPDE4C
SCHEMBL7139875 0.73 ABL1 (0.41) ABL1PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed